March 2011 Archives

March 18, 2011

FDA Removes 500 Unapproved Prescription Drugs From The Market

The FDA has announced that it will be seeking to remove nearly 500 unapproved prescription drugs from the market. In a statement, the director of compliance at the Center for Drug Evaluation and Research notes that they "don't know what's in them, whether they work properly, or how they are made."

If believe you may have suffered a seriously or harmful side effect after taking a prescription drug, contact a New Mexico pharmaceutical malpractice lawyer for more information.

Often, a drug's potential for injury is unknown until patients begin reporting harmful side effects. It was only after years of studies and lawsuits that dangerous drugs such as Avandia and Vioxx received adequate warnings. Recent cases involving dangerous drugs such as Baycol, Bextra and Reglan have all brought to light the potential for debilitating side-effects and in some cases an increased chance of life-threatening effects from taking these harmful prescription drugs.

Continue reading "FDA Removes 500 Unapproved Prescription Drugs From The Market" »

March 8, 2011

Topamax Linked To Birth Defects

The New York Times reports that Topamax, manufactured by Johnson & Johnson, has been linked to birth defects, such as a higher risk of developing cleft lips and palates, genital malformations and cranial malformations.

Topamax is an anti-seizure and migraine drug used in the treatment of migraines and epilepsy. It is also used in the weight-loss drug Qnexa.

Infants exposed to the dangerous drug during their mother's first trimester of pregnancy had a 3 times higher rate of mouth defects than those whose mothers took other seizure medications.

If you or a loved one has been harmed by taking Topamax, contact an experienced New Mexico Topamax attorney to discuss your options.

The FDA notes "doctors should think carefully before prescribing the drug to women of childbearing age and 'alternative medications that have a lower risk of birth defects should be considered.'"

Continue reading "Topamax Linked To Birth Defects" »